Joel DeCastro, MD, MPH, debunks some of the most common myths surrounding prostate cancer, like outdated beliefs about screening tests, treatment options, and its effect on sexual health.
Tal Korem, PhD, shares how his lab is using a new decontamination method to prevent blood-borne microbial DNA samples from contamination and improve cancer diagnostic tools.
During First Lady Jill Biden's Columbia Sept. 21 visit, she singles out patient, Mario Sambula and his special connection with clinical trials nurse navigator, Brianne Bodin.
Columbia Cancer congratulates Drs. Catherine Spina and Aaron Viny, recipients of a prestigious Clinical Scientist Development Award by the Doris Duke Charitable Foundation.
In Notes from the Lab, we spotlight the Giancotti lab and new research identifying factors that sustain prostate cancer cells that have become resistant to androgen receptor (AR) therapy.
Michael Shen, PhD, is a leading expert in prostate and bladder cancer research. His ongoing work with three-dimensional cultures--organoids--could contribute to the development of new therapies.